UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Awards Program (CTSA) consortium, led by the
National Institutes of HealthNational Center for Advancing Translational Sciences (NCATS). Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members. The ACTRI News and Funding Opportunities is a monthly newsletter.
ACTRI Special Announcements
ACTRI and IEM Announce 2018 Galvanizing Engineering in Medicine Awards Four clinician-engineer teams from UC San Diego have been selected to receive the 2018 Galvanizing Engineering in Medicine (GEM) awards. GEM, an initiative of UC San Diego Altman Clinical and Translational Research Institute (ACTRI) and UC San Diego Institute of Engineering in Medicine (IEM), brings engineers and clinicians together to develop innovative technologies that can be applied to solving challenging problems in medical care. This year’s projects address challenges in the areas of urology, telerobotic surgery, oncology, and spinal cord injuries. “We are extremely pleased to announce this year’s recipients of the Galvanizing Engineering in Medicine awards. The projects are impressive, ranging from developing novel treatments for paralysis and pancreatic cancer to innovative improvements for telerobotic surgery and urinary catheters,” said Deborah Spector, PhD, chair of the GEM Committee and co-director of the ACTRI Translational Research Alliance.
Read more
ACTRI Partners with ACT Network to Bring Cohort Exploration Tool to UC San Diego Researchers UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is pleased to announce that it has partnered with the Accrual to Clinical Trials (ACT) Network to bring real-time cohort exploration and discovery to its researchers. ACT was developed by members of the Clinical and Translational Science Awards (CTSA) Program consortium to enable cohort discovery using a web interface in a HIPAA-compliant manner, without requiring study-specific IRB approval. It offers open-access to a national network of leading academic medical research centers and generates aggregate patient count data from an investigator's real-time, iterative searches. Using ACT, UC San Diego Health researchers can explore patient populations, confirm and demonstrate study feasibility, and identify potential partners for multi-site studies. ACTRI is one of the first 21 CTSA hubs across the country to launch the ACT Network.
Read more
Funding Opportunities
NEWACTRI Invites Applications for 2019 Academic-Community Pilot Project Awards—Due 10/15
NEWACTRI Invites Applications for 2019 Dissemination & Implementation Pilot Project Awards—Due 10/22
NEWACTRI Invites Applications for KL2 Training Support for Junior Faculty—Due 11/12
NEWUC CAI Seeks Pitch Day Applications—Due 9/24
ACTRI Vouchers for ACTRI Research Services (In-kind)
NCATS Open Funding Opportunities
ACTRI News and Features
Cannabis and Breast Milk Study by ACTRI Researcher Chambers Sparks News Coverage ACTRI leader Christina Chambers, PhD, MPH, is spotlighted in news outlets across the country for her recently published study about marijuana concentrations in breast milk. Dr. Chambers and the research team reported that traces of marijuana can be found in breast milk up to six days after use. The results were published in the journal
Pediatrics on August 27 and broadly featured in the news media, including in the
New York Times, CNN, CBS, Fox, and
USA Today. Dr. Chambers will speak on medication safety in pregnancy and breastfeeding on November 6 at the ACTRI Auditorium as part of the ACTRI Seminar Series.
Read more |
   
In This Issue
Upcoming Seminars ACTRI Seminar Series
The National Opioid Crisis: Is Cannabis Helpful or Harmful?
Thursday, September 20, 2018
2 p.m.
ACTRI Building, First-floor Auditorium
Presented by:
Mark S. Wallace, MD
Professor of Clinical Anesthesiology
Chair, Div. of Pain Medicine
Dept. of Anesthesiology
Co-Director, ACTRI Division of Clinical Research
UC San Diego
Ignorance is Not Bliss: The Need for Better Data on Medication Safety in Pregnancy and Breastfeeding
Tuesday, November 6, 2018
2 p.m.
ACTRI Building, First-floor Auditorium
Presented by:
Christina Chambers, PhD, MPH
Co-Director, Center for Better Beginnings
Professor, Div. of Dysmorphology and Teratology
Dept. of Pediatrics
Director, ACTRI Center for Life Course Research
UC San Diego
ACTRI-Supported Ethics Forum
Ethical Boundaries of Research with Human Embryos
Wednesday, October 3, 2018
5-7 p.m.
UC San Diego
Fleet Science Center
Community Forum Presented by:
Mana Parast MD, PhD
Professor, Pathology
UC San Diego
and
Louise Laurent, MD, PhD
Associate Professor, Reproductive Medicine
UC San Diego
Cite the Grant
Don’t forget to cite the grant! To help ensure resources are available for future research,
please cite the UCSD ACTRI CTSA grant. Projects and Publications using UCSD ACTRI resources must cite the UCSD ACTRI grant and follow the NIH Public Access Policy.
ACTRI News and Funding Opportunities
Gary S. Firestein, MD
Director of ACTRI
Eric Mah
Chief Administrative Officer
Patricia Wieser
Communications Director
Tracy Dezenzo
Graphic Designer |